gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE American · RVPHealthcareSurgical Instruments

Retractable Technologies, Inc (RVP)

$0.5660+0.71%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$0.57▼ 35.75% in range
Nov 3, 2025Low $0.56 · High $0.88Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Retractable Technologies closed at $0.57 on Nov 4, up 0.71%, within 0.7% of its 52-week closing low. Volume of 32.7K shares was 0.86× its 20-day average (close to normal).

Split-adjusted performance: -18.1% over one month, -18.3% over six months, -35.8% over one year.

In the quarter ended Jun 30, 2026, revenue was $7.20M, down 31.1% from a year earlier, with a net margin of 38.5%.

Short interest was 27.2K shares at the Oct 15 settlement, down 50.6% from the prior report (0.2% of float, 1.0 days to cover).

Market cap$16.9M29.9M shares
Revenue · quarter$7.2M−31.1% YoY
Diluted EPS$0.09—
P/E · TTM—P/S 0.5×
Net margin38.5%Gross 2.7%
Dividend yieldNone
52-week range0.56 – 0.88−35.8% from high
Volume32.7K0.86× 20-day avg
Volatility · 60d25.9%Annualised
Short % of float0.2%1.0 days to cover
Net cash$39.2MCash $39.9M
Next earnings—Not scheduled
Split-adjusted performance
1W −2.9%1M −18.1%3M −16.4%6M −18.3%YTD −26.7%1Y −35.8%3Y −48.5%5Y −93.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum39
Revenue growth5
Net margin99
Value (low P/E)—
Size23

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →
Shares short27.2K−50.6% vs prior
Days to cover1.0Settled Oct 15
% of float0.2%
Short vol. 10d52.2%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
RVPRetractable Technologies$0.5660+0.71%−18.3%−31.1%38.5%—$16.9M
PMIPicard Medical$7.19−7.58%−38.0%—−191.6%—$16.8MCompare
ARAYAccuray Incorporated$0.1491+3.97%−68.7%−20.9%−1.9%—$17.8MCompare
MODDModular Medical$1.67−5.65%−57.3%———$15.9MCompare
CTSOCytosorbents$4.56+0.44%−60.0%+0.2%−45.9%—$14.4MCompare
PAVMPAVmed$1.66−8.79%−76.3%+450.0%−16603.0%—$13.3MCompare
GUTSFractyl Health$0.9725+8.27%−89.0%———$12.9MCompare
SINTSiNtx Technologies$1.66−3.49%−30.8%+199.3%−803.5%—$12.5MCompare
FEMYFemasys$1.44+2.86%−84.1%−18.9%−1346.8%—$12.1MCompare

News about Retractable Technologies

All news →

No recent articles focused on Retractable Technologies.

Quick answers

What does Retractable Technologies do?
Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well.
What is RVP's market cap?
$16.94M, based on the Nov 4 close of $0.57.
Does Retractable Technologies pay a dividend?
No regular cash dividend has been paid in the last year.
How much of RVP is sold short?
27.2K shares, 0.2% of float, as of Oct 15, 2026.
What sector is RVP in?
Healthcare, in the Surgical Instruments industry.

About Retractable Technologies

Retractable Technologies Inc is engaged in the manufacturing and marketing of safety medical products (predominantly syringes) for the healthcare industry. It has manufacturing facilities in Little Elm, Texas, and uses manufacturers in China as well. Its syringes are well-suited for administering vaccinations. The company's products are VanishPoint Syringe, VanishPoint Insulin Syringes, EasyPoint Needle, EasyPoint Blood Collection Tube with Needle, VanishPoint Blood Collection Set, and VanishPoint IV Catheter. It provides solutions such as Insulin, Immunization, Blood Collection, Allergy, General Purpose, and Infusion.

HQ: Little Elm, TX201 employeesListed May 4, 2001retractable.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology